More than 5 million Americans are living with Alzheimer's disease and by 2050, without a cure, this number may reach 16 million. In Connecticut alone there are 77,000 individuals living with the disease and 178,000 unpaid caregivers. Alzheimer's disease is the sixth-leading cause of death in the United States and the only cause of death among the top 10 that cannot be prevented, treated or cured. With one in eight Americans over 65 living with Alzheimer's, it is likely that you already know someone impacted by the disease.
The Alzheimer's Association is the leading voluntary health organization in Alzheimer's care, support and research. As the largest nonprofit funder of Alzheimer's disease research in the world and the nonprofit organization with the highest impact in Alzheimer's research, ranking third overall behind only the U.S. and Chinese governments, the Alzheimer's Association is a global leader in Alzheimer's disease research.
Through an integrated, multifaceted Global Research Program the Alzheimer's Association seeds, speeds and leads the best Alzheimer's science worldwide. The Association has helped catalyze nearly every major advancement in Alzheimer's research.
The Alzheimer's Association also convenes and facilitates collaboration in the research field and advocates for increased government funding of research. The Association's aim is to realize the national goal of preventing and effectively treating Alzheimer's disease by 2025.
The Alzheimer's Association Connecticut Chapter is the primary source of information and support to the thousands of Connecticut residents dealing with the effects of Alzheimer's disease or a related dementia. With offices across the state in Norwalk, Norwich, New Milford, Hamden and our main office in Southington, we are able to offer our communities 24/7 Helpline support 1.800.272.3900, family training seminars, care consultations, Safe Return training, support groups and educational programs for both healthcare professionals and caregivers. The Chapter has influenced public policy changes and has provided support to Alzheimer's and dementia research in the hope of finding a cure.
For additional information, please visit our website.